The primary objectives of this study are to (1) work closely with the SEER working groups and NCI to develop and implement algorithms that would be applied to SEER-Medicare data to identify oligodendrogliomas, female breast and endometrial, and prostate cancers diagnosed from 1992-2009 that received radiation, chemotherapy, hormone, and/or immunotherapy treatment;and, (2) define the process for incorporating additional information into the existing SEER treatment variables in SEER*DMS.
